224 related articles for article (PubMed ID: 3368106)
21. Alternation of chemotherapy and radiotherapy in cancer management. I. Summary of the Division of Cancer Treatment Workshop.
Looney WB; Goldie JH; Little JB; Hopkins HA; Read EJ; Wittes R
Cancer Treat Rep; 1985; 69(7-8):769-75. PubMed ID: 4016787
[No Abstract] [Full Text] [Related]
22. Long-term health status among survivors of childhood cancer: does sex matter?
Armstrong GT; Sklar CA; Hudson MM; Robison LL
J Clin Oncol; 2007 Oct; 25(28):4477-89. PubMed ID: 17906209
[TBL] [Abstract][Full Text] [Related]
23. [Present and future of therapeutic oncology].
García G; Beltrán-Ortega A; Díaz-Perches R; de la Garza-Salazar JG; Noriega-Limón J; Jiménez-Zamudio L
Gac Med Mex; 1984; 120(7-8):281-300. PubMed ID: 6526215
[No Abstract] [Full Text] [Related]
24. Antioxidants and other nutrients do not interfere with chemotherapy or radiation therapy and can increase kill and increase survival, Part 2.
Simone CB; Simone NL; Simone V; Simone CB
Altern Ther Health Med; 2007; 13(2):40-7. PubMed ID: 17405678
[TBL] [Abstract][Full Text] [Related]
25. Combined modality therapy of lung cancer.
Livingston RB
Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2638-47. PubMed ID: 10068267
[TBL] [Abstract][Full Text] [Related]
26. [Radiotherapy combined with hormonal therapy as treatment method in patients with prostate cancer: still more questions than answers].
Milecki P
Przegl Lek; 2005; 62(12):1455-9. PubMed ID: 16786772
[TBL] [Abstract][Full Text] [Related]
27. New concepts for phase I trials: evaluating new drugs combined with radiation therapy.
Deutsch E; Soria JC; Armand JP
Nat Clin Pract Oncol; 2005 Sep; 2(9):456-65. PubMed ID: 16264990
[TBL] [Abstract][Full Text] [Related]
28. Concurrent chemotherapy and "concomitant boost" radiotherapy for unresectable head and neck cancer.
Teh BS; Monga U; Thornby J; Gressot L; Parke RB; Donovan DT
Am J Otolaryngol; 2000; 21(5):306-11. PubMed ID: 11032294
[TBL] [Abstract][Full Text] [Related]
29. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.
van den Belt-Dusebout AW; de Wit R; Gietema JA; Horenblas S; Louwman MW; Ribot JG; Hoekstra HJ; Ouwens GM; Aleman BM; van Leeuwen FE
J Clin Oncol; 2007 Oct; 25(28):4370-8. PubMed ID: 17906202
[TBL] [Abstract][Full Text] [Related]
30. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000.
National Institutes of Health Consensus Development Panel
J Natl Cancer Inst Monogr; 2001; (30):5-15. PubMed ID: 11773285
[TBL] [Abstract][Full Text] [Related]
31. [Quality control in oncology. Document any incidents!].
Betzler M
MMW Fortschr Med; 2004 Aug; 146(31-32):18. PubMed ID: 15529701
[No Abstract] [Full Text] [Related]
32. A practical approach to the older patient with cancer.
Balducci L; Extermann M
Curr Probl Cancer; 2001; 25(1):6-76. PubMed ID: 11261937
[No Abstract] [Full Text] [Related]
33. [Established data and practical recommendations concerning pre- and postoperative chemotherapy of rectal cancer].
Rougier P; Mitry E; Clavéro-Fabri MC; Penna C; Nordlinger B
Ann Chir; 1999; 53(10):1011-8. PubMed ID: 10670150
[TBL] [Abstract][Full Text] [Related]
34. Principles of feeding cancer patients via enteral or parenteral nutrition during radiotherapy.
Fietkau R
Strahlenther Onkol; 1998 Nov; 174 Suppl 3():47-51. PubMed ID: 9830457
[TBL] [Abstract][Full Text] [Related]
35. Are frailty markers useful for predicting treatment toxicity and mortality in older newly diagnosed cancer patients? Results from a prospective pilot study.
Puts MT; Monette J; Girre V; Pepe C; Monette M; Assouline S; Panasci L; Basik M; Miller WH; Batist G; Wolfson C; Bergman H
Crit Rev Oncol Hematol; 2011 May; 78(2):138-49. PubMed ID: 20444620
[TBL] [Abstract][Full Text] [Related]
36. Preoperative evaluation of the oncology patient.
Sahai SK; Zalpour A; Rozner MA
Med Clin North Am; 2010 Mar; 94(2):403-19. PubMed ID: 20380962
[TBL] [Abstract][Full Text] [Related]
37. Ovarian function following radiation and chemotherapy for cancer.
Lo Presti A; Ruvolo G; Gancitano RA; Cittadini E
Eur J Obstet Gynecol Reprod Biol; 2004 Apr; 113 Suppl 1():S33-40. PubMed ID: 15041128
[TBL] [Abstract][Full Text] [Related]
38. The case for adjuvant therapy for prostate cancer.
Glodé LM
J Urol; 2006 Dec; 176(6 Pt 2):S30-3. PubMed ID: 17084163
[TBL] [Abstract][Full Text] [Related]
39. Increased risk of high-grade dermatologic toxicities with radiation plus epidermal growth factor receptor inhibitor therapy.
Tejwani A; Wu S; Jia Y; Agulnik M; Millender L; Lacouture ME
Cancer; 2009 Mar; 115(6):1286-99. PubMed ID: 19170238
[TBL] [Abstract][Full Text] [Related]
40. Recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2) immunotherapy with ranimustine chemotherapy and concurrent radiation therapy for malignant astrocytomas.
Fukushima T; Yamamoto M; Oshiro S; Tsugu H; Hirakawa K; Soma G
Anticancer Res; 2003; 23(6a):4473-81. PubMed ID: 14666736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
